Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SOHO 2020 | ZUMA-1: outcomes of CAR-T in older patients

Sattva S Neelapu, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, outlines the outcomes of a post-hoc analysis of the ZUMA-1 study (NCT02348216) in older patients (65 years or older). In this subgroup, safety and efficacy were reported to be largely similar compared to the younger patient population, highlighting the promise of CAR T-cell therapies for older patients. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).